Biological Barcoding Market Size
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 144.70 Million |
| Market Size (2030) | USD 225.80 Million |
| CAGR (2025 - 2030) | 9.30% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Biological Barcoding Market Analysis
The Biological Barcoding Market size is estimated at USD 144.70 million in 2025, and is expected to reach USD 225.80 million by 2030, at a CAGR of 9.30% during the forecast period (2025-2030).
Biological barcoding is a method for identifying and classifying organisms based on short, standardized DNA or RNA sequences, known as "barcodes," typically found in specific genomic regions. This technique allows researchers to rapidly and accurately differentiate between species, even morphologically similar species. The biological barcoding market is expected to witness significant growth in the coming years due to advancements in genomics, increasing biodiversity research, and expanding applications in various industries. The application of this technology is driving the market growth.
Biological barcoding enables the unique identification and tracking of individual cells in complex biological samples. The emergence of genomic DNA barcoding as a sensitive and adaptable tool for tracking clonal sub-populations within heterogeneous cancer cell populations is propelling the growth of the biological barcoding market. For instance, a research study article published by Trends Cancer in April 2023 revealed that the origins of tumor cell diversity, the roles of selection, and phenotypic plasticity in disease progression and therapeutic resistance have positioned DNA barcoding as an indispensable technology in cancer research. Such studies are expected to propel the overall market's growth over the forecasted period.
Additionally, in recent years, development in nanotechnology utilization of DNA barcodes with the potential benefit of nanoparticulate systems is a hallmark for novel advancements in healthcare, biomedical, and research sectors. For instance, in March 2023, a study published in the International Journal of Biological Macromolecules highlighted the advantages of combining biological barcoding with a nanodimensional system. This integration boasts benefits like ultra-sensitivity and error-free accuracy, requiring fewer label reagents and less time. These advantages stand in stark contrast to traditional techniques such as ELISA, PCR, culture media, and electrophoresis, underscoring its capability to swiftly and precisely identify a diverse array of species from minimal samples. These factors are expected to contribute to the market's growth over the forecasted period.
Therefore, the integration of DNA barcoding and gene expression recording for cancer cell detection and the advancement of biological barcoding with nanotechnology, offering enhanced sensitivity, accuracy, and efficiency compared to traditional techniques, will boost the demand for biological barcoding in different disease studies. However, high initial costs and technical challenges will restrain the biological barcoding market during the forecast period
Biological Barcoding Market Trends
Healthcare Industry Expected to Register Healthy Growth Over the Forecast Period
Barcoding tools offer substantial attention in drug delivery, in-vivo screening, gene transport for theranostics, bioimaging, and nano-biosensors applications. The healthcare industry's strong focus on precision medicine and personalized healthcare has driven the adoption of biological barcoding technologies for accurate diagnosis, treatment monitoring, and disease management.
Barcoding enables precise identification of biomarkers, pathogens, and genetic variations crucial for clinical diagnostics. For instance, in October 2023, researchers from Imperial College London collaborated with Oxford Nanopore Technologies to develop a new method combining nanopore sequencing and DNA barcoding for diagnosing diseases. Traditional blood tests typically focus on a limited number of biomarkers. This innovative approach allows the simultaneous analysis of dozens of biomarkers of various types from a single clinical sample.
Furthermore, in a proof-of-concept study, researchers detected 40 distinct types of miRNA molecules, broadening the horizon for potential biomarkers. The testing process combines blood samples with DNA barcodes and employs the handheld MinION device to interpret electrical signatures from nanopores, ensuring a detailed profile for accurate disease diagnosis. These factors are expected to boost the segmental's growth during the forecasted period.
Moreover, healthcare institutions invest significantly in research and development to advance understanding of diseases, drug mechanisms, and patient outcomes. Biological barcoding facilitates high-throughput screening, genomics, and proteomics studies, aiding in the discovery of novel biomarkers and therapeutic targets. For instance, in September 2024, in Yale School of Medicine developed Patho-DBiT, a novel pathology tool that uses DNA barcoding to map RNA and proteins in tissue, offering a potential breakthrough in cancer diagnosis and patient-specific treatment.This advancement not only improves disease understanding and patient outcomes but also signifies the industry's commitment to leveraging biological barcoding for transformative healthcare solutions, thereby driving the segment's growth over the forecasted period.
Thus, all the above-mentioned factors are expected to propel the segment growth during the forecast period.
North America Segment is Expected to Dominate the Biological Barcoding Market during the Forecast Period
North America has dominated the biological barcoding market due to factors such as robust research infrastructure, significant investments in biotechnology, a high adoption rate of advanced technologies, strong collaborations between academia and industry, and a supportive regulatory environment, all contributing to the region's leadership in driving innovation and market expansion in biological barcoding technologies.
Increasing research and development activities to develop technological advancements in biological barcodes are expected to boost market growth in the North American region. For instance, in September 2024, researchers at Weill Cornell Medicine in the United States developed barcode cells to track the highways by which prostate cancer spreads throughout the body. Previously, how metastatic cancer spreads remained unclear. This achievement paves the way for developing new, more targeted therapeutics.These factors are expected to significantly contribute to the country's expansion over the forecasted period.
Moreover, North America has stringent regulatory standards for healthcare and food industries to ensure safety, emphasizing the need for precise identification and tracking of specimens. This also drives the adoption of biological barcoding in the region. For instance, in July 2023, researchers from the National Oceanic and Atmospheric Administration, the United States Food and Drug Administration, the Smithsonian Institution, and the Philippine National Fisheries Research and Development Institute released the first batch of fish DNA barcodes, curated DNA sequences that can be used to identify and authenticate seafood. Such instances are anticipated to drive the growth of the segment throughout the forecast period.
Hence, owing to these factors, the demand for the biological barcoding market is expected to grow in the North America region during the forecast period.
Biological Barcoding Industry Overview
The market studied is consolidated, owing to a small number of market players. The biological barcoding market is characterized by intense competition among key players striving to enhance their product offerings, expand their market presence, and leverage advancements in technology. Some market players are Bio-Rad Laboratories, Inc., Eurofins Scientific, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies plc., and Bioserve Biotechnologies (India) Private Ltd. among others.
Biological Barcoding Market Leaders
-
Bio-Rad Laboratories, Inc.
-
Eurofins Scientific
-
Thermo Fisher Scientific Inc.
-
Oxford Nanopore Technologies plc.
-
Bioserve Biotechnologies (India) Private Ltd.
- *Disclaimer: Major Players sorted in no particular order
Biological Barcoding Market News
- March 2024: Biodiversity Genomics Europe selected six projects for funding to develop DNA-barcoding reference libraries for species in Europe. They were barcoding of central-eastern mediterranean insects, busting caucasus barcode of life database, inclusion of lepidoptera from the Caucasus region to the DNA barcoding reference library, invertebrate fauna of Bulgaria and adjacent areas –DNA-based barcoding of under-represented in reference libraries taxa, understudied biodiversity in the depths of dinarides and unraveling the hidden world of alpine fungi in Italy and Slovenia.
- February 2023: Duke School of Medicine scientists unveiled a pioneering technique. This method employs DNA barcoding to pinpoint the plant-based foods consumed by an individual.
Biological Barcoding Industry Segmentation
As per the scope of the report, biological barcoding is a method used to identify and classify species by analyzing short, standardized DNA sequences from a particular region of the genome. This method is widely used in biodiversity studies, ecological research, agriculture, forensics, and healthcare.
The biological barcoding market is segmented by product, applications, and end users. In terms of products, the market is segmented into kits & reagents, and services. By application, the market is segmented in the identification and monitoring of pathogens, product authentication, and others. By end-user, the market is segmented as pharmaceutical and biotechnology companies, academic centers and research institutes, agriculture and food industries, and others. By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (USD) for the above segments.
| By Product | Kits & Reagents | ||
| Services | |||
| By Application | Identification and Monitoring Pathogens | ||
| Product Authentication | |||
| Others | |||
| By End User | Pharmaceutical and Biotechnology Companies | ||
| Academic Centers and Research Institutes | |||
| Agriculture and Food Industries | |||
| Others | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Rest of the World | |||
| Kits & Reagents |
| Services |
| Identification and Monitoring Pathogens |
| Product Authentication |
| Others |
| Pharmaceutical and Biotechnology Companies |
| Academic Centers and Research Institutes |
| Agriculture and Food Industries |
| Others |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| Australia | |
| South Korea | |
| Rest of Asia-Pacific | |
| Rest of the World |
Biological Barcoding Market Research FAQs
How big is the Biological Barcoding Market?
The Biological Barcoding Market size is expected to reach USD 144.70 million in 2025 and grow at a CAGR of 9.30% to reach USD 225.80 million by 2030.
What is the current Biological Barcoding Market size?
In 2025, the Biological Barcoding Market size is expected to reach USD 144.70 million.
Who are the key players in Biological Barcoding Market?
Bio-Rad Laboratories, Inc., Eurofins Scientific, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies plc. and Bioserve Biotechnologies (India) Private Ltd. are the major companies operating in the Biological Barcoding Market.
Which is the fastest growing region in Biological Barcoding Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Biological Barcoding Market?
In 2025, the North America accounts for the largest market share in Biological Barcoding Market.
What years does this Biological Barcoding Market cover, and what was the market size in 2024?
In 2024, the Biological Barcoding Market size was estimated at USD 131.24 million. The report covers the Biological Barcoding Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Biological Barcoding Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
